Pediatrix Medical Group, Inc.MDEarnings & Financial Report
NYSE
NextFeb 27, 2026
MD Q3 2025 Key Financial Metrics
Revenue
$492.9M
Gross Profit
N/A
Operating Profit
$68.1M
Net Profit
$71.7M
Gross Margin
N/A
Operating Margin
13.8%
Net Margin
14.5%
YoY Growth
-3.6%
EPS
$0.84
Financial Flow
Pediatrix Medical Group, Inc. Q3 2025 Financial Summary
Pediatrix Medical Group, Inc. reported revenue of $492.9M for Q3 2025, with a net profit of $71.7M (14.5% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $492.9M |
|---|---|
| Net Profit | $71.7M |
| Gross Margin | N/A |
| Operating Margin | 13.8% |
| Report Period | Q3 2025 |
Pediatrix Medical Group, Inc. Annual Revenue by Year
Pediatrix Medical Group, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.0B).
| Year | Annual Revenue |
|---|---|
| 2024 | $2.0B |
| 2023 | $2.0B |
| 2022 | $2.0B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $496.4M | $495.1M | $504.3M | $511.2M | $502.4M | $458.4M | $468.8M | $492.9M |
| YoY Growth | -3.4% | 0.8% | 0.7% | 0.9% | 1.2% | -7.4% | -7.0% | -3.6% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $2.22B | $2.17B | $2.00B | $2.08B | $2.15B | $1.99B | $2.10B | $2.20B |
| Liabilities | $1.37B | $1.31B | $1.29B | $1.34B | $1.39B | $1.20B | $1.27B | $1.31B |
| Equity | $849.1M | $856.2M | $706.5M | $732.5M | $764.9M | $789.2M | $833.8M | $890.7M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $69.3M | $-125.2M | $107.0M | $91.8M | $133.0M | $-117.5M | $137.2M | $137.3M |